M42 to showcase cutting-edge diagnostic capabilities at ADLM Middle East 2024

UAE—M42, a global leader in healthcare technology and the largest healthcare provider in the Middle East, is set to highlight its extensive diagnostic capabilities at the upcoming ADLM Middle East Conference and Exposition.

Scheduled for November 23-24, 2024, the event will take place at Conrad Abu Dhabi Etihad Towers and will bring together professionals in laboratory medicine to explore advancements in diagnostics. 

M42’s diagnostic services are anchored by the expertise of the National Reference Laboratory (NRL) and the Omics Centre of Excellence.

These institutions are supported by a team of highly skilled clinical experts, ensuring comprehensive and cutting-edge diagnostic solutions.

Organized by the Association of Diagnostics & Laboratory Medicine (ADLM), a global organization dedicated to clinical laboratory science, the event provides a platform for industry leaders to discuss emerging trends in laboratory medicine. 

The National Reference Laboratory is a cornerstone of the UAE’s healthcare system, conducting over 10 million diagnostic tests annually.

It offers more than 5,000 tests through its network of ten state-of-the-art laboratories. By combining scientific expertise, artificial intelligence, and advanced technology, the NRL delivers fast, accurate, and high-quality results.

This ensures efficient clinical support, reduces turnaround times, and enhances the overall quality of laboratory services in the region. 

Dr. Laila AbdelWareth, CEO of NRL, emphasized the laboratory’s commitment to advancing medical education and adopting international best practices in laboratory medicine.

She noted that their internationally accredited labs, staffed by world-class pathologists and scientists, offer specialized diagnostic expertise across various medical disciplines.

By staying at the forefront of technological innovations, the NRL continues to support public health initiatives, improve patient outcomes, and strengthen the UAE’s healthcare infrastructure. 

Meanwhile, M42’s Omics Centre of Excellence leads transformative projects like the Emirati Genome Program (EGP), managed in collaboration with the Department of Health—Abu Dhabi.

This initiative has sequenced the genomes of over 600,000 Emiratis, enabling a shift from conventional healthcare to a prevention-based, personalized model.

Programs like premarital screening and pharmacogenomics leverage genetic insights to identify risks early, enhance diagnostic accuracy, and reduce financial burdens for patients. 

Dr. Val Zvereff, Medical Director of Clinical Genomics at the Omics Centre of Excellence, highlighted how genomic initiatives are revolutionizing care by enabling precise, predictive, and preventive solutions.

He explained that whole genome sequencing improves diagnostic accuracy for rare diseases by 31% compared to standard methods.

This innovative approach empowers clinicians with actionable data, transforming healthcare delivery and setting new global benchmarks in population genomics. 

As a platinum sponsor of the event, M42 will host experts at Booth 65 to share insights into the technological advancements driving its diagnostic excellence.

Key presentations include Dr. Adrian G. Miller discussing high-sensitivity troponin tests for rapid heart attack assessment, Dr. Zvereff speaking on population genomics, and Dr. AbdelWareth moderating a session on advances in cardiac and metabolic disease testing. 

Sign up HERE to receive our email newsletters with the latest news and insights from Africa and around the world, and follow us on our WhatsApp channel for updates.